|
Patients with severe tricuspid regurgitation [3-4], n ( %) |
162
(18.493) |
Lead dependent tricuspid valve dysfunction (LDTD) |
Average LDTD
[0-4], mean±SD |
3,541±0.594 |
|
Patients with LDTD (any), n ( %) |
60 (6.410) |
|
Patients with severe LDTD [3-4,] n ( %) |
58
(96.667) |
Any shadows on the leads |
Patients with any shadows on leads before
TLE, n (%) |
607 (64.850) |
Patients with fibrous tissue binding the lead to the vena cava superior
and heart structures, n (%) |
Patients with fibrous tissue binding the
lead to the vena cava superior and heart structures, n (%) |
236
(25.214) |
Fibrous tissue binding the lead to the vena cava superior and heart
structures
|
Fibrous tissue binding the lead to the heart structures
(all), n (%)
|
316 (33.761)
|
|
Fibrous tissue binding the lead to the SVC, n (%) |
56
(5.983) |
|
Fibrous tissue binding the lead to the RA wall, n (%) |
65
(6.944) |
|
Fibrous tissue binding the lead to the tricuspid apparatus,
n (%)
|
90 (9.615)
|
|
Fibrous tissue binding the lead to the RV wall, n (%) |
105
(11.218) |
Fibrous tissue binding two leads, n (%) |
Fibrous tissue binding two
leads, n (%) |
172 (18.377) |
Patients with asymptomatic masses on endocardial leads (AMEL) (patient
analysis), n (%) |
Patients with asymptomatic masses on endocardial
leads (AMEL) (patient analysis), n (%) |
437 (46.688) |
AMEL (findings analysis) |
AMEL (all), n (%) |
549
(58.654) |
|
Fibrous tissue encasing the lead,
n ( % of all ILM / % of all pts)
|
160
(29,144 / 17.094)
|
|
Lead thickening, n ( % of all ILM / % of all pts)
|
277
(50,455 / 29.594)
|
|
Clot on the lead, n (% of all ILM / % of all pts)
|
75
(13,661 / 8.013)
|
|
Vegetation-like masses, n ( % of all ILM / % of all pts)
|
37
(6,740 / 3.953)
|
Presence of vegetations |
Patients with vegetations, n (%) |
119
(12.727) |
Excess lead loops in the heart |
Patients with lead loops in the heart
(any), n (%) |
181 (19.338) |
|
Lead loops in the RA n (%) |
138 (14.744) |
|
Lead loops in the TV, n (%) |
35 (3.793) |
|
Lead loops in the RV or PA, n (%) |
28 (2.991) |
Perforation or penetration of the lead through the cardiac wall up to
the epicardium |
Perforations, n (%) |
151 (16.132) |